PLA Officer and Board of Director Nominations

The Nominating Committee recommends the following slate of candidates to serve in the Officer and available at-large Board member positions.

In accordance with the Bylaws of the Pacific Lipid Association, the office of the President and Immediate Past-President are not elected. The offices of the President-Elect, the Treasurer, and the Secretary are elected. If affirmed at the NLA meeting in May, these PLA members take their respective roles immediately following the PLA Annual Business Meeting.

*Please note, the Nominating Committee is seeking the endorsement and support of the PLA Board of Directors

2011-2012 Pacific Lipid Association Executive Committee

Those Nominated to Serve in At-Large Direction Positions

President
John R. Nelson, MD
Fresno, CA

Immediate Past-President
Edward A. Gill, MD
Seattle, WA

President-Elect
J. Antonio G. Lopez, MD, FACC, FAHA
Boise, ID

Treasurer
B. Alan Bottenberg, DO
Carson City, NV

Secretary
Paul D. Rosenblit, MD, PhD, FACE
Huntington Beach, CA

Term Expiring 2013
Robert G. Thompson, MD
Seattle, WA

Term Expiring 2014
Brian M. Chesnie, MD
Newport Beach, CA

Robert S. Greenfield, MD, FACC, FAHA
Fountain Valley, CA

Kevin P. Maguire, DO
Anchorage, AK

Beth Malasky, MD
Boise, ID

Drew Garcia, PA-C
Boise, ID

Michael S. Shapiro, DO
Portland, OR

Wayne S. True, MD, MPH
La Mesa, CA

See Sections 4.2 and 5.1 of the PLA Bylaws regarding nominations from the floor.

4.2 Election of Officers
(a) The President, President-Elect, Secretary, and Treasurer are elected for a term of one (1) year, or until successors are elected, by a majority vote of the members present at the Business Meeting. Following the Nominating Committee's report, nominations for Officers may also be made from the floor of the Annual Meeting provided that a petition, signed by at least ten (10) active members in support of each nominee, has been received by the Board of Directors at least thirty (30) days prior to the Business Meeting.
(b) All Officers shall immediately assume their respective offices and the President-Elect shall automatically succeed to President at the end of the Business Meeting

5.1 Election of the Board of Directors
(a) The Board of Directors shall consist of a maximum of 23 members including the President, President-Elect, Secretary, Treasurer, Immediate Past-President, and general Board members.
(b) Excluding the Officers, valid nominations for at large positions on the Board shall include the recommendations of the Nominating Committee and nominations from the floor of the Business Meeting, provided that a petition signed by ten (10) members in support of each floor nominee has been submitted to the Board of Directors at least thirty (30) days prior to the Annual Meeting.

Nominating Committee Members
Matthew K. Ito, PharmD - Chair
Jamshid Faraji, MD
Drew Garcia, PA-C
John Nelson, MD
Jerry Tanner, DO

We would like to thank the following NLA member for his service to the PLA Board of Directors:
Craig D. Williams, PharmD, Portland, OR